Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8992408 | 0.84 | ALDH1A1 (0.33) | ATM | |
| SCHEMBL8992324 | 0.81 | ATM (0.32) | ATM | |
| SCHEMBL8992275 | 0.77 | MAOB (0.32) | — | |
| Hydrochloric Acid SCHEMBL8992323 | 0.76 | MAOB (0.33) | — | |
| Hydrochloric Acid SCHEMBL8992342 | 0.75 | LMNA (0.37) | — | |
| SCHEMBL8992438 | 0.70 | SLC6A2 (0.34) | ATMMAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL8992338 | 0.70 | CHRM2 (0.37) | — | |
| SCHEMBL9586923 | 0.68 | HSD11B1 (0.34) | ATM | |
| Hydrochloric Acid SCHEMBL8992580 | 0.68 | HTR2A (0.39) | MAPT | |
| SCHEMBL8992333 | 0.68 | SLC6A2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0445749-B1 | N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-07-10 | — | — | EP | disclosed |
| US-5256824-A | Anticholinergic agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-10-26 | — | — | US | disclosed |
| EP-0445749-A1 | N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-09-11 | — | — | EP | disclosed |